Wed Sep 25 09:23:30 UTC 2024: ## Shield Therapeutics Shares Surge 9.4% on Wednesday

**Gateshead, UK – September 25th, 2024** – Shares of Shield Therapeutics plc (LON:STX) soared 9.4% on Wednesday, reaching a high of GBX 4.18 ($0.06) before closing at GBX 3.94 ($0.05). This surge in price comes after a significant decrease in trading volume, with 3,379,912 shares exchanging hands, representing a 32% drop from the average daily volume.

The company’s current ratio stands at 1.05, quick ratio at 2.16, and debt-to-equity ratio at 3,691.50. Shield Therapeutics has a market capitalization of £31.13 million, a price-to-earnings ratio of -90.00, and a beta of 1.42. The 50-day moving average price for the stock is GBX 3.55, while the 200-day moving average price sits at GBX 2.44.

Shield Therapeutics is a specialty pharmaceutical company dedicated to commercializing pharmaceuticals for unmet medical needs. The company’s flagship product is Accrufer/Feraccru, a non-salt based oral therapy for adults struggling with iron deficiency, with or without anemia. Established in 2008, Shield Therapeutics is headquartered in Gateshead, United Kingdom.

Read More